The sales are small relative to market cap and occur after a strong earnings beat, suggesting routine portfolio diversification rather than negative signaling. Monitor next quarter's insider activity for any change in pattern, particularly if C-suite officers increase selling volume.
REGN drugs
REGN drug pipeline →- ● Otarmeni 3/10 Approved (accelerated approval) · BLA filing 2026
- ▲ Cemdisiran 6/10 Filed/PDUFA (Phase 3 NIMBLE complete; NDA under FDA Priority Review)
- ▲ Dupixent 4/10 Approved (marketed since 2017; additional Phase 3 trials ongoing for label expansion)
- ● Evkeeza 4/10 Approved
- ● EYLEA HD 4/10 Approved
- 12 more · All REGN drugs, catalysts & trials →
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $904.35entry
- T+1 · 8d ago +1.73%α −0.64% · $919.96
- T+5 · 4d ago +5.65%α +3.06% · $955.47
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Seven Regeneron insiders sold a total of $9.56M in open-market sales over the week following a strong Q3 earnings beat (revenue +36% YoY, EPS +35% YoY). The sales include two C-suite executives (EVP General Counsel and EVP Commercial) and five directors; two of the sales were under 10b5-1 plans. The total represents ~0.01% of market cap, well below the 0.1% threshold for materiality, making this a routine cluster likely driven by post-earnings window openings and personal portfolio management.
Key Financial Metrics
Key Facts
- Seven insiders sold $9.56M in open-market sales (code S) over a 7-day window ending Nov 4, 2026
- Sales follow Q3 2026 earnings on Oct 30: revenue $5.116B (+36% YoY), GAAP EPS $18.45 (+35% YoY), both above consensus
- Total sales are ~0.01% of $96.3B market cap, far below the 0.1% materiality threshold
- Two sales (Brown, McCourt, Guarini) were under 10b5-1 plans; four were not; one (Pitofsky) is detailed separately with derivative exercises
- No C-suite CEO or CFO sales; the most senior sellers are EVPs and directors
- The cluster includes non-cash derivative exercises and gifts by Zoghbi, Murphy, and Pitofsky that have no economic impact
Financial Impact
Total open-market sales of $9.56M, representing ~0.01% of market cap
Risk Factors
- Insider sales after a strong earnings beat could be interpreted negatively by some market participants, but the size is immaterial
- No C-suite CEO/CFO sales reduces signaling value
- Two sales under 10b5-1 plans indicate pre-planned trades, not reactive selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-REGN-1793998938623 |
Track record
53 reports on REGN
11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
- Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
- Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Viewing Entry $904.35 Now $952.40 +5.31% settles Dec 7
- Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
- Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers